Gene Review:
CHAF1A - chromatin assembly factor 1, subunit A (p150)
Homo sapiens
Synonyms:
CAF, CAF-1, CAF-1 subunit A, CAF-I 150 kDa subunit, CAF-I p150, ...
- Secretion of biologically active human epidermal growth factor from Escherichia coli using Yersinia pestis Caf1 signal peptide. Liu, Y.L., Huang, L.M., Lin, W.P., Tsai, C.C., Lin, T.S., Hu, Y.H., Chen, H.S., Han, J.M., Wang, H.J., Liu, Y.T. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. (2006)
- Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Neijt, J.P., ten Bokkel Huinink, W.W., van der Burg, M.E., van Oosterom, A.T., Vriesendorp, R., Kooyman, C.D., van Lindert, A.C., Hamerlynck, J.V., van Lent, M., van Houwelingen, J.C. Lancet (1984)
- CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Mackewicz, C.E., Blackbourn, D.J., Levy, J.A. Proc. Natl. Acad. Sci. U.S.A. (1995)
- CAF in metastatic breast cancer: standard therapy or another effective regimen? Hayes, D.F., Henderson, I.C. J. Clin. Oncol. (1987)
- Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Shibahara, K., Stillman, B. Cell (1999)
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Konopka, J.B., Watanabe, S.M., Witte, O.N. Cell (1984)
- Heterochromatin dynamics in mouse cells: interaction between chromatin assembly factor 1 and HP1 proteins. Murzina, N., Verreault, A., Laue, E., Stillman, B. Mol. Cell (1999)
- Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. Parnes, H.L., Cirrincione, C., Aisner, J., Berry, D.A., Allen, S.L., Abrams, J., Chuang, E., Cooper, M.R., Perry, M.C., Duggan, D.B., Szatrowski, T.P., Henderson, I.C., Norton, L. J. Clin. Oncol. (2003)
- Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. Rosner, G.L., Hargis, J.B., Hollis, D.R., Budman, D.R., Weiss, R.B., Henderson, I.C., Schilsky, R.L. J. Clin. Oncol. (1996)
- Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869. Guidi, A.J., Berry, D.A., Broadwater, G., Helmchen, B., Bleiweiss, I.J., Budman, D.R., Henderson, I.C., Norton, L., Hayes, D.F. J. Clin. Oncol. (2002)
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. Peters, W.P., Ross, M., Vredenburgh, J.J., Meisenberg, B., Marks, L.B., Winer, E., Kurtzberg, J., Bast, R.C., Jones, R., Shpall, E. J. Clin. Oncol. (1993)
- A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage. Moggs, J.G., Grandi, P., Quivy, J.P., Jónsson, Z.O., Hübscher, U., Becker, P.B., Almouzni, G. Mol. Cell. Biol. (2000)
- Induction of CAF-1 expression in response to DNA strand breaks in quiescent human cells. Nabatiyan, A., Szüts, D., Krude, T. Mol. Cell. Biol. (2006)
- Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Polo, S.E., Theocharis, S.E., Klijanienko, J., Savignoni, A., Asselain, B., Vielh, P., Almouzni, G. Cancer Res. (2004)
- Structural analysis of the group II intron splicing factor CRS2 yields insights into its protein and RNA interaction surfaces. Ostheimer, G.J., Hadjivassiliou, H., Hadjivasiliou, H., Kloer, D.P., Barkan, A., Matthews, B.W. J. Mol. Biol. (2005)
- Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma. Sizemore, G.W., Hpeath, H., Larson, J.M. J. Clin. Invest. (1975)
- Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Levy, J.A., Mackewicz, C.E., Barker, E. Immunol. Today (1996)
- Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. McGrath, T., Center, M.S. Cancer Res. (1988)
- Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil. O'Reilly, S.E., Gelmon, K.A., Onetto, N., Parente, J., Rubinger, M., Page, R.A., Plenderleith, I.H. J. Clin. Oncol. (1993)
- Ccr4 contributes to tolerance of replication stress through control of CRT1 mRNA poly(A) tail length. Woolstencroft, R.N., Beilharz, T.H., Cook, M.A., Preiss, T., Durocher, D., Tyers, M. J. Cell. Sci. (2006)
- The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Mackewicz, C.E., Craik, C.S., Levy, J.A. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Transcriptional activation by NF-kappaB requires multiple coactivators. Sheppard, K.A., Rose, D.W., Haque, Z.K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M.G., Glass, C.K., Collins, T. Mol. Cell. Biol. (1999)
- Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain. Shim, K.S., Bergelson, J.M., Furuse, M., Ovod, V., Krude, T., Lubec, G. J. Neural Transm. Suppl. (2003)
- Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products. Hengstschläger, M., Rosner, M., Fountoulakis, M., Lubec, G. Biochem. Biophys. Res. Commun. (2003)
- Separation of Crotalus atrox (western diamondback rattlesnake) alpha-proteinase from serine proteinase and hemorrhagic factor activities. Kruzel, M., Kress, L.F. Anal. Biochem. (1985)
- Purification, properties and alternate substrate specificities of arginase from two different sources: Vigna catjang cotyledon and buffalo liver. Dabir, S., Dabir, P., Somvanshi, B. Int. J. Biol. Sci. (2005)
- Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors. Cummings, F.J., Gelman, R., Horton, J. J. Clin. Oncol. (1985)
- Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188). Davidson, N.E., O'Neill, A.M., Vukov, A.M., Osborne, C.K., Martino, S., White, D.R., Abeloff, M.D. J. Clin. Oncol. (2005)